Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Analysis 2012-2017 and Forecast 2018-2023

Report ID: PR6998 Category: Pages: 115 99Strategy

$3,300$6,600

Clear

Snapshot
The Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Benign Prostatic Hyperplasia (BPH) Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Alpha-blocker
Phosphodiesterase Type-5 Inhibitors
5-alpha-Reductase Inhibitors
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Astellas Pharma
Eli Lilly
GlaxoSmithKline
Sanofi
ADC Therapeutics
Bayer HealthCare
Bristol-Myers Squibb
Valeant Pharmaceuticals
Endo Pharmaceuticals
Foresee Pharmaceuticals
Madrigal Pharmaceuticals
Merck
Novartis
Spectrum Pharmaceuticals
Takeda Pharmaceuticals
Teva
Advaxis
ANI Pharmaceuticals
BHR Pharma
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospitals
Clinics
Others
Region Coverage (Regional Production, Demand & Forecast by Regions etc.):
China
Japan & Korea
India
Southeast Asia
Oceania

Report ID: PR6998 Category: Pages: 115 99Strategy

Table of Content
1 Industry Overview
1.1 Benign Prostatic Hyperplasia (BPH) Drugs Industry
1.1.1 Overview
1.1.2 Development of Benign Prostatic Hyperplasia (BPH) Drugs
1.2 Market Segment
1.2.1 By Product Type
1.2.2 By Application
1.3 Asia-Pacific Overview
2 Major Companies List
2.1 Astellas Pharma (Company Profile, Products & Services, Sales Data etc.)
2.2 Eli Lilly (Company Profile, Products & Services, Sales Data etc.)
2.3 GlaxoSmithKline (Company Profile, Products & Services, Sales Data etc.)
2.4 Sanofi (Company Profile, Products & Services, Sales Data etc.)
2.5 ADC Therapeutics (Company Profile, Products & Services, Sales Data etc.)
2.6 Bayer HealthCare (Company Profile, Products & Services, Sales Data etc.)
2.7 Bristol-Myers Squibb (Company Profile, Products & Services, Sales Data etc.)
2.8 Valeant Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.9 Endo Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.10 Foresee Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.11 Madrigal Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.12 Merck (Company Profile, Products & Services, Sales Data etc.)
2.13 Novartis (Company Profile, Products & Services, Sales Data etc.)
2.14 Spectrum Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.15 Takeda Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.16 Teva (Company Profile, Products & Services, Sales Data etc.)
2.17 Advaxis (Company Profile, Products & Services, Sales Data etc.)
2.18 ANI Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.19 BHR Pharma (Company Profile, Products & Services, Sales Data etc.)
3 Market Competition
3.1 Company Competition
3.2 Regional Market by Company
4 Benign Prostatic Hyperplasia (BPH) Drugs Market by Type
4.1 By Type
4.1.1 Alpha-blocker
4.1.2 Phosphodiesterase Type-5 Inhibitors
4.1.3 5-alpha-Reductase Inhibitors
4.2 Market Size
4.3 Market Forecast
5 Market Demand
5.1 Demand Situation
5.1.1 Demand in Hospitals
5.1.2 Demand in Clinics
5.1.3 Demand in Others
5.2 Regional Demand Comparison
5.3 Demand Forecast
6 Region Operation
6.1 Regional Production
6.2 Regional Market
6.3 by Region
6.3.1 China
6.3.1.1 By Type
6.3.1.2 By Application
6.3.2 Japan & Korea
6.3.2.1 By Type
6.3.2.2 By Application
6.3.3 India
6.3.3.1 By Type
6.3.3.2 By Application
6.3.4 Southeast Asia
6.3.4.1 By Type
6.3.4.2 By Application
6.3.5 Oceania
6.3.5.1 By Type
6.3.5.2 By Application
6.4 Regional Forecast
7 Marketing & Price
7.1 Price and Margin
7.1.1 Price Trends
7.1.2 Factors of Price Change
7.1.3 Manufacturers Gross Margin Analysis
7.2 Marketing Channel
8 Upstream & Cost
8.1 Upstream
8.2 Cost
9 Industry Environment
9.1 Policy
9.2 Economics
9.3 Sociology
9.4 Technology
10 Research Conclusion

Figure Benign Prostatic Hyperplasia (BPH) Drugs Industry Chain Structure
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth Rate 2012-2023
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Market, by Company, in 2018
Figure Japan & Korea Benign Prostatic Hyperplasia (BPH) Drugs Market, by Company, in 2018
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Market, by Company, in 2018
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Market, by Company, in 2018
Figure Oceania Benign Prostatic Hyperplasia (BPH) Drugs Market, by Company, in 2018
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Growth 2012-2017, by Type, in USD Million
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Growth 2012-2017, by Type, in Volume
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2012-2017, in USD Million
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2012-2017, in Volume
Figure Japan & Korea Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2012-2017, in USD Million
Figure Japan & Korea Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2012-2017, in Volume
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2012-2017, in USD Million
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2012-2017, in Volume
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2012-2017, in USD Million
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2012-2017, in Volume
Figure Oceania Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2012-2017, in USD Million
Figure Oceania Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2012-2017, in Volume
Figure Marketing Channels Overview